Insider trades
G. Walmsley Graham, Director of Olema Pharmaceuticals OLMA, has filed 20 purchases and 6 sales on the open market. The latest trade was on 06/18.
G. Walmsley Graham
Director
- Company
- Olema Pharmaceuticals OLMA
- First filing
- 23/05/23
- Trades
- 48 trades
- Buys / sales
- 20 / 6
- 12-month net buying
- No record
- Last trade
- 06/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/03/25–25/03/27 | 25/03/27 | 200,000 sh3 trades | $43.94avg. | $8,787,877.66 | +20.0% | |
| Open-market buy | 25/01/30 | 25/02/07 | 200,000 sh | $48.00 | $9,600,000 | +25.0% | |
| Open-market buyAmendment | 24/12/13 | 24/12/18 | 700,761 sh | $6.75 | $4,730,136.75 | No record | |
| Open-market saleAmendment | 24/12/13 | 24/12/18 | 700,761 sh | $6.75 | $4,730,136.75 | −100.0% | |
| Open-market buy | 24/12/17 | 24/12/17 | 700,761 sh | $6.75 | $4,730,136.75 | −33.2% | |
| Open-market sale | 24/12/17 | 24/12/17 | 700,761 sh | $6.75 | $4,730,136.75 | −100.0% | |
OLMA | Open-market saleAmendment | 24/06/04 | 24/11/26 | 1,175,000 sh2 trades | $14.85avg. | $17,448,750 | −62.4% |
OLMA | Open-market sale | 24/06/04 | 24/06/06 | 1,175,000 sh2 trades | $14.85avg. | $17,448,750 | −62.4% |
OLMA | Open-market buy | 23/09/12–23/12/05 | 23/12/18 | 640,000 sh4 trades | $10.74avg. | $6,871,444.3 | +55.2% |
| Open-market buy | 23/12/08 | 23/12/11 | 100,000 sh2 trades | $19.83avg. | $1,982,500 | +14.3% | |
| Open-market buy | 23/11/30–23/12/01 | 23/12/05 | 100,000 sh2 trades | $16.95avg. | $1,694,500 | +16.7% | |
| Open-market buy | 23/08/08 | 23/08/10 | 25,000 sh | $42.06 | $1,051,500 | +4.3% | |
| Open-market buy | 23/07/28–23/08/01 | 23/08/01 | 55,000 sh2 trades | $42.95avg. | $2,362,200 | +10.6% | |
| Open-market buyAmendment | 22/09/19–23/05/19 | 23/06/15 | 520,000 sh2 trades | $29.69avg. | $15,440,000 | No record | |
| Open-market buy | 23/05/19–23/09/19 | 23/05/23 | 520,000 sh2 trades | $29.69avg. | $15,440,000 | No record |